- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc stock price live, this page displays NASDAQ MRKR stock exchange data. View the MRKR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Marker Therapeutics Inc real time stock price chart below.
What Is the Marker Therapeutics Inc Stock Price Today?
The Marker Therapeutics Inc stock price today is 1.185.
What Is the Stock Symbol for Marker Therapeutics Inc?
The stock symbol for Marker Therapeutics Inc is ""MRKR.""
What Stock Exchange Does Marker Therapeutics Inc Trade On?
Marker Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Marker Therapeutics Inc a Good Stock to Buy?
Determining whether Marker Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRKR quote. (ISIN: US57055L2060)
What Is the Marker Therapeutics Inc Stock Price Today?
The Marker Therapeutics Inc stock price today is 1.185.
What Is the Stock Symbol for Marker Therapeutics Inc?
The stock symbol for Marker Therapeutics Inc is ""MRKR.""
What Stock Exchange Does Marker Therapeutics Inc Trade On?
Marker Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Marker Therapeutics Inc a Good Stock to Buy?
Determining whether Marker Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRKR quote. (ISIN: US57055L2060)
NASDAQ
Currency in USD
1.185
-0.045(-3.66%)
Real-time Data·
Fair Value
An estimate of a Marker Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.180
1.240
52 wk Range
0.950
5.950
MRKR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Marker Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1801.240
52 wk Range
0.9505.950
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MRKR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Marker Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.000
Upside
+406.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Marker Therapeutics Inc Company Profile
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Compare MRKR to Peers and Sector
Metrics to compare | MRKR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRKRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −1.0x | −0.5x | |
PEG Ratio | 0.01 | −0.02 | 0.00 | |
Price/Book | 0.9x | 1.3x | 2.6x | |
Price / LTM Sales | 2.4x | 9.2x | 3.3x | |
Upside (Analyst Target) | 391.8% | 410.8% | 43.4% | |
Fair Value Upside | Unlock | 42.1% | 7.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.000
(+406.33% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.40 / -0.32
Revenue / Forecast
349.10K / --
People Also Watch
FAQ
What Stock Exchange Does Marker Therapeutics Trade On?
Marker Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Marker Therapeutics?
The stock symbol for Marker Therapeutics is "MRKR."
What Is the Marker Therapeutics Market Cap?
As of today, Marker Therapeutics market cap is 13.52M.
What Is Marker Therapeutics's Earnings Per Share (TTM)?
The Marker Therapeutics EPS (TTM) is -1.34.
From a Technical Analysis Perspective, Is MRKR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Marker Therapeutics Stock Split?
Marker Therapeutics has split 5 times.
How Many Employees Does Marker Therapeutics Have?
Marker Therapeutics has 5 employees.
What is the current trading status of Marker Therapeutics (MRKR)?
As of 08 Aug 2025, Marker Therapeutics (MRKR) is trading at a price of 1.19, with a previous close of 1.23. The stock has fluctuated within a day range of 1.18 to 1.24, while its 52-week range spans from 0.95 to 5.95.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.